Home / What’s new? / Patents

Patents

Sort by:
YearTitle
DescendingAscending

Patent

Preparation of sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Number
WO 2019/008029 A1, WO 2019/166633 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

Sulfonamide derivates as NLRP3 inhibitors and their preparation

Number
WO 2019/166633 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

1,2,4-triazolederivatives as tankyrase inhibitors

Number
WO 2019/243822 A1
Year
2019
Customer
Oslo University
Site
Nijmegen
Department
Discovery
MCS People
Anita Wegert, Ruben Leenders
Patent

Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazole

Number
WO2019/197239 A1
Year
2019
Customer
Bayer Pharma
Site
Nijmegen
Department
Development
MCS People
Richard van der Haas, René Gieling
Patent

Novel compounds

Number
WO2019/166629A1, WO2019/166632 A1, WO2019/211463 A1
Year
2019
Customer
Inflazome
Site
Groningen
Department
MCS People
Jim van Wiltenburg, Hans Meissner, Jochem van Herpt, Ken Lion
Patent

Novel sulfonamide carboxamide compounds

Number
WO2019/008025A1, WO2019/034696A1, WO2019/034697A1, WO2019/034686A1
Year
2019
Customer
Inflazome
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

Triazoloquinazolinone synthesis

Number
WO2019/123011 A1
Year
2019
Customer
Gabather Ab
Site
Nijmegen
Department
Development
MCS People
Thomas Jagusch, Peter Zenhorst, Paula van der Aa, Goran Verspui, Martin Kas, Martina Scigelova
Patent

Triazole derivatives as tankyrase inhibitors

Number
WO2018118868A1
Year
2018
Customer
Oslo University Hospital Hf
Site
Nijmegen
Department
Discovery
MCS People
Anita Wegert, Ruben Leenders
Patent

Process for preparing a grease

Number
WO 2017/017020 A1
Year
2017
Customer
Shell
Site
Groningen
Department
Development
MCS People
Ton Visser, Don van Zwieten
Patent

Therapeutic compounds for pain and synthesis thereof

Number
WO2017/040764 A1WO2017/040767 A1WO2017/040770 A1WO2017/040772 A1WO2017/040778 A1
Year
2017
Customer
Janssen Pharma-ceutica N.V.
Site
Nijmegen
Department
Discovery
MCS People
Bart DeCorte, Jaap Russcher, Menno Monnee

* indicates required



 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
Scroll to top